Back
Trevi Therapeutics Stock Price Chart
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!
Buy
65
TRVI
Trevi Therapeutics
Last Price:
2.61
Seasonality Move:
9.86%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.- The current trend is moderately bearish and TRVI is experiencing slight selling pressure.
Trevi Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.93 | Buy |
| 20-day SMA: | 2.83 | Buy |
| 50-day SMA: | 3.03 | Sell |
| 200-day SMA: | 2.1 | Buy |
| 8-day EMA: | 2.92 | Buy |
| 20-day EMA: | 2.9 | Buy |
| 50-day EMA: | 2.81 | Buy |
| 200-day EMA: | 2.31 | Buy |
Trevi Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 50.95 | Buy |
| Chaikin Money Flow: | -17303 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.72 - 3.04) | Buy |
| Bollinger Bands (100): | (1.51 - 3.11) | Buy |
Trevi Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
- Trevi Therapeutics share price is 2.93 while TRVI 8-day simple moving average is 2.93, which is a Buy signal.
- The stock price of TRVI is 2.93 while Trevi Therapeutics 20-day SMA is 2.83, which makes it a Buy.
- Trevi Therapeutics 50-day simple moving average is 3.03 while TRVI share price is 2.93, making it a Sell technically.
- TRVI stock price is 2.93 and Trevi Therapeutics 200-day simple moving average is 2.10, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
65
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a Buy
The current Trevi Therapeutics [TRVI] share price is $2.93. The Score for TRVI is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
202.05M
Price in USD:
2.93
Share Volume:
60.56K
Trevi Therapeutics 52-Week Range
52-Week High:
4.00
52-Week Low:
0.97
Buy
65
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?
The Trevi Therapeutics stock price is 2.93 USD today. -
Will TRVI stock go up or go down?
Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Trevi Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
- Trevi Therapeutics share price is 2.93 while TRVI 8-day exponential moving average is 2.92, which is a Buy signal.
- The stock price of TRVI is 2.93 while Trevi Therapeutics 20-day EMA is 2.90, which makes it a Buy.
- Trevi Therapeutics 50-day exponential moving average is 2.81 while TRVI share price is 2.93, making it a Buy technically.
- TRVI stock price is 2.93 and Trevi Therapeutics 200-day simple moving average is 2.31, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
- TRVI Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Trevi Therapeutics is a Sell
- Trevi Therapeutics Relative Strength Index (RSI) is 50.95, which suggest Trevi Therapeutics is overbought
- The Bollinger Bands (25) for Trevi Therapeutics is (2.72 - 3.04), which suggest Trevi Therapeutics is a Buy
- The Bollinger Bands (100) for Trevi Therapeutics is (1.51 - 3.11), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.